País: Reino Unido
Língua: inglês
Origem: MHRA (Medicines & Healthcare Products Regulatory Agency)
Ampicillin sodium; Flucloxacillin sodium
Wockhardt UK Ltd
J01CA51
Ampicillin sodium; Flucloxacillin sodium
250mg ; 250mg
Powder for solution for injection
Intramuscular; Intravenous
No Controlled Drug Status
Valid as a prescribable product
BNF: 05010103
MEASURE BAR SHOULD BE 150MM AT 100% SCALE Customer Description Item Code Profile Size Min. Point Size Market Language Proof By Proof No. Date Artwork No. Pharma Code Colours Used Wockhardt UK Limited Co-fluampicil (Magnapen) injection leaflet 107018/3 n-a 190 x 470mm matt.pirie-scott 3 17/11/2015 610826 n/a Process Black Keyline (does not print) artwork.leicester@MULTIPKG.com CLEARLY MARK ANY AMENDMENTS ON ONE PROOF AND RETURN TO MPS WARNING! We cannot accept responsibility for any errors in this proof after approval. Whilst we take extreme care at all times to ensure accuracy to our clientʼs brief, the final responsibility must be taken by our client. IF YOU SIGN THIS PROOF YOU ARE SIGNIFYING FULL APPROVAL OF DESIGN AND TEXT. UK English 8.5pt (main body) / 9pt (variables) PACKAGE LEAFLET INFORMATION FOR THE USER MAGNAPEN 250MG/250MG POWDER FOR SOLUTION FOR INJECTION OR INFUSION (AMPICILLIN AND FLUCLOXACILLIN) READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE. - Keep this leaflet. You may need to read it again. - If you have further questions, please ask your doctor or nurse. - This medicine has been prescribed for you personally and you should not pass it on to others. It may harm them, even if their symptoms are the same as yours The name of your medicine is Magnapen 250mg/250mg Powder for Solution for Injection or Infusion. In the rest of this leaflet it is called Magnapen Injection. IN THIS LEAFLET: 1. What Magnapen Injection is and what it is used for 2. Before you are given Magnapen Injection 3. How Magnapen Injection should be given 4. Possible side effects 5. How to store Magnapen Injection 6. Further information 1. WHAT MAGNAPEN INJECTION IS AND WHAT IT IS USED FOR Magnapen Injection contains two active ingredients, ampicillin and flucloxacillin which together are known as co-fluampicil. Magnapen Injection is an antibiotic medicine. It belongs to the penicillin group of antibiotics and works by killing bacteria that cause infections. Magnapen Injection is used to treat a wide range Leia o documento completo
OBJECT 1 MAGNAPEN 250MG/250MG POWDER FOR SOLUTION FOR INJECTION OR INFUSION Summary of Product Characteristics Updated 22-Apr-2016 | Wockhardt UK Ltd 1. Name of the medicinal product Magnapen® 250mg/250mg Powder for Solution for Injection or Infusion or Co-fluampicil 250mg/250mg Powder for Solution for Injection or Infusion 2. Qualitative and quantitative composition Co-fluampicil 500mg Vials contain 250mg ampicillin as ampicillin sodium with 250mg flucloxacillin as flucloxacillin sodium (co-fluampicil 250/250). 3. Pharmaceutical form Powder for Solution for Injection or Infusion 4. Clinical particulars 4.1 Therapeutic indications Co-fluampicil is indicated for the treatment of severe infections where the causative organism is unknown, and for mixed infections involving β-lactamase-producing staphylococci. Typical indications include: _In general practice:_ Chest infections, ENT infections, skin and soft tissue infections, and infections in patients whose underlying pathology places them at special risk. _In hospital_ (prior to laboratory results being available): severe respiratory tract infections, post-operative chest and wound infections, septic abortion, puerperal fever; septicaemia, prophylaxis in major surgery, infections in patients receiving immuno-suppressive therapy. The spectrum of activity of co-fluampicil also makes it suitable for the treatment of many mixed infections, particularly those where β-lactamase-producing staphylococci are suspected or confirmed. Parenteral usage is indicated where oral dosage is inappropriate. 4.2 Posology and method of administration USUAL ADULT DOSAGE (INCLUDING ELDERLY PATIENTS AND CHILDREN OVER TEN YEARS): _Intramuscular/Intravenous: _500mg four times a day_._ USUAL CHILDREN'S DOSAGE: _Intramuscular/Intravenous: _Under 2 years: quarter adult dose, four times a day. 2-10 years: half adult dose, four times a day. The above dosages for adults and children may be doubled where necessary. Therapy may be continued for as long as it is indicated by the nature of infecti Leia o documento completo